Introduction
Endoscopic endonasal approaches (EEA) to the cranial base are increasingly being utilized to address a variety of cranial base pathological processes. [1] [2] [3] [4] [5] [6] [7] Historically, one limitation of this approach was that large cranial base defects would not rapidly heal after reconstruction with synthetic materials or free tissue grafts; therefore, patients suffered unacceptably high rates of postoperative cerebrospinal fluid (CSF) leakage. This limitation was dramatically reduced (from an incidence of over 30% to approximately 3-5%) with the introduction of the pedicled Keywords ► indocyanine green ► ICG ► fluorescence ► indocyanine green fluorescence ► indocyanine green endoscope ► endoscopic endonasal ► nasoseptal flap ► nasoseptal artery ► skull base
Abstract
Objectives The pedicled nasoseptal flap (NSF) has dramatically reduced postoperative cerebrospinal fluid leakage following endoscopic endonasal approach (EEA) surgery. Although rare, its arterial supply may be damaged during harvest or may be preoperatively damaged for numerous reasons. Early recognition permits harvesting a contralateral flap before sacrificing its pedicle as part of the surgical exposure or use of an alternative flap. Design Technical feasibility study and case series. Setting Tertiary care university-associated medical center. Participants Five patients requiring an EEA with NSF reconstruction. Main Outcome Measures During NSF harvest, intravenous indocyanine green (IVICG) was administered, and a customized endoscopic system was used to visualize the emerging fluorescence. At the end of each case, just before final positioning of the NSF, additional IVICG was administered, and the custom endoscope was again introduced to evaluate fluorescence. Results In four patients, the entire NSF fluoresced brightly with IVICG on initial harvest and before final positioning. One patient showed heterogeneous fluorescence of the pedicle and distal parts of the NSFat both stages. All NSFs healed well without complication. Conclusion IVICG facilitates real-time evaluation NSF's arterial supply. This may provide early recognition of arterial compromise, allowing the harvest of alternate flaps or modification of surgery.
nasoseptal flap. This technique provided viable, vascularized tissue capable of rapidly healing and adhering to the bone surrounding the defect; thus, effectively sealing it.
8,9
When harvesting the flap, it is crucial to avoid injuring the nasoseptal artery on which it is pedicled. Intraoperative Doppler acoustic ultrasonography may be utilized to identify its presence and location; however it provides poor spatial resolution and sensitivity.
10 Real-time evaluation of the location and patency of the vessel would be helpful not only during the process of harvesting the nasoseptal flap but also in assessing the patency of its blood supply should cause iatrogenic arterial injury (such as with electrocautery near its origin). In this case, an alternate flap for reconstruction could be harvested during the early stages of surgery before sacrificing the arterial supply to potential alternate flaps. Indocyanine green (ICG) fluorescence has long been utilized for real-time angiography in vascular neurosurgery. [11] [12] [13] [14] [15] With the advent of the ICG-responsive endoscope, surgeons began exploring its use in endonasal skull base surgery. 16, 17 However, its utility in delineating the arterial supply of the nasal mucosa has not yet been investigated. We report our prospective case series utilizing ICG to investigate the integrity of blood supply during the harvest and use of nasoseptal flaps for cranial defect repair during endonasal skull base surgery.
Materials and Methods

Patient Population
This investigation was performed at the Ohio State University Wexner Medical Center with the approval of its Institutional Review Board. We prospectively identified adult patients with skull base lesions who were candidates for an EEA for resection and a nasoseptal flap for reconstruction. Exclusion criteria included patient age less than 18 years, history of iodide allergy, previous anaphylactic reaction to ICG, pregnancy, history of septal surgery for any reason, and preoperative lack of indication for nasoseptal flap harvest. All surgeries were performed by a team comprising of a neurosurgeon and an otolaryngologist-head and neck surgeon.
Indocyanine Green Fluorescence Endoscopy
All cases were performed with standard, commercially available rigid 0 and 30-degree endoscopes (4 mm diameter, 18 cm length; Karl Storz Endoscopy-America, Inc., El Segundo, California, United States) for all aspects of the surgery except at two distinct times: immediately prior to the nasoseptal flap harvest and just before its final positioning over the defect. Specialized endoscopic equipment was used during these time intervals to evaluate the fluorescence of the tissues. To evaluate the nasoseptal flap fluorescence, 25 mg of ICG were dissolved in 10 mL of normal saline solution and injected intravenously as a bolus followed by a flush of 10 mL of normal saline solution. The emerging and resulting fluorescence was observed with a 0-degree rigid endoscope (5. 
Results
During this pilot study, we enrolled two men and three women, ranging in age from 24 to 78 years (mean: 48.8 years). Indications for surgery included one type-2 craniopharyngioma, 18 two planum sphenoidale meningiomas, one esthesioneuroblastoma, and one encephalocele. ►Table 1 summarizes the relevant information. ICG was successfully administered intravenously to all patients without adverse event. Approximately 20 seconds after injection, the ICG fluorescence, indicating the vascularity of the nasal mucosa, was clearly visible. In four patients, the entire flap fluoresced brightly after administration of ICG upon initial harvest (►Fig. 1) and before final positioning (►Fig. 2). One patient showed heterogeneous fluorescence of the pedicle and distal parts of the flap. The surgeons decided to still use this flap for skull base reconstruction since there was perfusion. This patient was followed closely postoperatively, and the flap proved to survive with no CSF leak thus far after 8 months. The fluorescent nasoseptal artery could be clearly seen through the mucosa in two patients, and the position of the artery was obscured by the intense fluorescence of the mucosal pedicle in the other three patients. All nasoseptal flaps fluoresced after final positioning. No patient experienced an adverse reaction to the ICG. Postoperative magnetic resonance images of the brain with and without contrast were obtained from each patient, and all demonstrated avid nasoseptal flap enhancement, indicating a patent blood supply. ►Fig. 3 provides a characteristic example of this enhancement.
Discussion
Originally Food and Drug Administration approved for human use in 1959, ICG is a tricarbocyanine dye with nearinfrared fluorescence. Since 1972, ICG has been used routinely in a variety of cerebrovascular procedures for real-time Intraoperative ICG to Evaluate Nasoseptal Flap Viability Kerr et al. 409
noninvasive intraoperative angiography; thus, it has long safety history. [11] [12] [13] [14] [15] It is administered as an intravenous bolus, typically in a dose of 25 mg (dissolved in 10 mL of sterile water), binds to large plasma proteins within 2 seconds, remains intravascular, is metabolized exclusively by the liver with a plasma half-life of 150 seconds, and is excreted in bile. 17 Angiography is typically most useful after about 45 seconds of ICG administration in distinct arterial, capillary, and venous phases.
17
ICG administration resulted in avid fluorescence in the nasoseptal mucosa in each of our patients approximately 20 seconds post administration, and the fluorescence persisted for minutes. We did not measure the time for the fluorescence to dissipate, as doing so would needlessly have prolonged surgery. However, in each case, no residual fluorescence was observed after final positioning of the nasoseptal flap following the administration of the second bolus of ICG. In our series, the ICG administration was well tolerated by the patients. This was expected, as ICG is routinely used in open vascular neurosurgery and for the evaluation of other reconstructive flaps (i.e., traditional open surgeries) at our institution without adverse event.
With the advent of the nasoseptal flap, postoperative CSF leak rates following expanded (extrasellar) EEA cases have declined from around 30 to about 5%. Any flap, however, can fail due to poor blood supply caused by injury to its supplying vessels or thrombosis of its vasculature. Unfortunately, after harvesting the flap, arterial insufficiency is not immediately evident with a visual inspection or even with Doppler ultrasonography. It should be considered that sinonasal Fig. 1 True-color and ICG-fluorescence images of the nasoseptal flap just before harvest in the patient with a type-2 craniopharyngioma (patient 1). In this case, the flap enhanced so avidly and uniformly that the enhancement of the underlying arterial supply was not discernable. ICG, indocyanine green; IT, inferior turbinate; SS, sphenoid sinus. dissection beyond this point in the surgery involves sacrificing the contralateral nasoseptal artery as the surgeon either prepares a reverse flap, 19 or simply removes the mucosal pedicle that carries the nasoseptal artery to the septal mucosa along the anterior face of the sphenoid sinus. Consequently, if ICG is administered just after harvesting the flap and the flap does not fluoresce (and the surrounding mucosa does, providing a positive control), then the surgeon could harvest a contralateral nasoseptal flap while the option still exists. Similarly, if a nasoseptal flap does not fluoresce after final positioning of the repair, then the surgeon can surmise that its arterial supply has either become occluded by thrombus or was injured during the course of the case, and an alternate technique such as multilayered grafting with or without a substitute flap such as a lateral nasal wall, 20 pericranial or temporoparietal fascia 21 flap may be considered before terminating the case. Finally, it is important to consider cost when evaluating any novel technology. ICG has been commercially available for decades as a generic medication, generally under US$100 as of the time of this study for a 25 mg vial, and the additional operating room time required to administer and observe the fluorescence twice was approximately 10 minutes total in our patients. As such, the cost of ICG administration is minimal, especially when compared with the savings in both direct costs and morbidity if doing so helps avoid a postoperative CSF leak requiring further management.
Conclusion
This novel technique for performing real-time endoscopic intranasal angiography provides immediate feedback regarding the success of arterial preservation during nasoseptal flap harvest and will similarly provide the surgeon with vital information regarding the viability of the flap at the conclusion of the reconstructive effort. This information, which is unavailable without real-time angiography, allows for further surgical action/intervention to avoid the complications associated with a nonviable flap and the potential CSF leak that would otherwise result.
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